CombiGene announces the final result of the offer to the shareholders and the holders of warrants in Panion
The Offer is not being made, and this press release may not be distributed, directly or
The Offer is not being made, and this press release may not be distributed, directly or
CombiGene concludes the offer to the shareholders and the holders of warrants in Panion, ends the
• When the initial acceptance period was due, the shareholders in Panion had accepted to transfer
The Offer is not being made, and this press release may not be distributed, directly or
CombiGene AB (publ) (“CombiGene”) today announces a public offer to the holders of shares (“Shares”) and
Initial data from CombiGene’s preclinical proof-of-concept-study (the long-term study) show that CombiGene’s candidate drug, CG01, has